Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | LEE, KUEN S. |
| Género | - |
| Área Principal WOS | Genetics & Heredity; Pharmacology & Pharmacy; |
| Afiliación Principal | Universidad De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Genetics & Heredity | 1 |
| Pharmacology & Pharmacy | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| QUINONES, LUIS A. | Hombre | 2 |
| GALLEGUILLOS, MACARENA | Mujer | 1 |
| CACERES-LILLO, DANTE DANIEL | Hombre | 1 |
| MIRANDA, CARLA | Mujer | 1 |
| TORRES, ROBERTO | Hombre | 1 |
| TARDÓN, KARLA | Mujer | 1 |
| VARELA, NELSON MIGUEL | Hombre | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Lee, Kuen S. | Universidad de Chile | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Editorial: Improving Cancer Chemotherapy Through Pharmacogenomics: A Research Topic | 2015 | 0 | material editorial | Frontiers In Genetics | WoS Scopus |
| Preliminary Pharmacogenomic Based Predictive Models Of Tamoxifen Response In Hormone Dependent Chilean Breast Cancer Patients | 2021 | 2 | artículo de investigación | Frontiers In Pharmacology | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| polymorphism | 2 |
| impact | 1 |
| therapy | 1 |
| relapse | 1 |
| recurrence | 1 |
| prostate-cancer | 1 |
| pharmacokinetics | 1 |
| pharmacogenomics | 1 |
| pharmacogenetics | 1 |
| pharmacodynamics | 1 |
| oncology | 1 |
| metabolite concentrations | 1 |
| metabolism | 1 |
| adjuvant breast | 1 |
| genetic polymorphisms | 1 |
| genetic | 1 |
| gene | 1 |
| estrogen-receptor | 1 |
| cyp2d6 genotype | 1 |
| clinical-outcomes | 1 |
| breast cancer | 1 |
| association | 1 |
| aromatase inhibitors | 1 |
| antineoplastic agents | 1 |
| adr | 1 |